byUniversity of California, Los AngelesA schematic overview highlighting the critical role of GRN in promoting inflammatory responses in TREM2 macrophages and IL-13RA1 in modulating the expressi
byUniversity of California, Los AngelesA schematic overview highlighting the critical role of GRN in promoting inflammatory responses in TREM2 macrophages and IL-13RA1 in modulating the expressi
Credit: Anna Tarazevich from PexelsSkin cancer is declining among younger adults in Sweden for the first time after decades of increases, making it the first European country to see a fall, researcher
Credit: Anna Tarazevich from PexelsSkin cancer is declining among younger adults in Sweden for the first time after decades of increases, making it the first European country to see a fall, researcher
byElsevierFitted temporal trend of invasive cutaneous melanoma incidence (1982- 2018) for males vs. females from three populations (Queensland, US Whites, Scotland), by body site. Credit:J
byElsevierFitted temporal trend of invasive cutaneous melanoma incidence (1982- 2018) for males vs. females from three populations (Queensland, US Whites, Scotland), by body site. Credit:J
byYale School of MedicineCredit: Unsplash/CC0 Public DomainPeople living with atopic dermatitis (AD, also known as eczema) are also at significantly higher risk for peripheral vascular disease (
byYale School of MedicineCredit: Unsplash/CC0 Public DomainPeople living with atopic dermatitis (AD, also known as eczema) are also at significantly higher risk for peripheral vascular disease (
by Lori SolomonLong-term treatment of adolescents with moderate-to-severe atopic dermatitis (AD) with upadacitinib is safe and effective through 76 weeks, according to a study published online Oct. 23
by Lori SolomonLong-term treatment of adolescents with moderate-to-severe atopic dermatitis (AD) with upadacitinib is safe and effective through 76 weeks, according to a study published online Oct. 23
byNational Jewish HealthCredit: CC0 Public DomainResearch at National Jewish Health and other institutions has shown that the biologic dupilumab improves signs and symptoms of moderate-to-severe
byNational Jewish HealthCredit: CC0 Public DomainResearch at National Jewish Health and other institutions has shown that the biologic dupilumab improves signs and symptoms of moderate-to-severe
byBoston University School of MedicineCredit: Pixabay/CC0 Public DomainDriven by rapid advances in technology and the ever-growing influence of the digital landscape, the art of caring for the p
byBoston University School of MedicineCredit: Pixabay/CC0 Public DomainDriven by rapid advances in technology and the ever-growing influence of the digital landscape, the art of caring for the p
by Deryn Lee Thompson,The ConversationCredit: CC0 Public DomainSo you've enjoyed a picnic in the sunshine. Or you've sat on the grass for a twilight concert. But you've come away wit
by Deryn Lee Thompson,The ConversationCredit: CC0 Public DomainSo you've enjoyed a picnic in the sunshine. Or you've sat on the grass for a twilight concert. But you've come away wit
FDA approves Nemluvio for moderate-to-severe atopic dermatitisby Lori SolomonThe U.S. Food and Drug Administration has approved Galderma's Nemluvio (nemolizumab) for the treatment of moderate-to-s
FDA approves Nemluvio for moderate-to-severe atopic dermatitisby Lori SolomonThe U.S. Food and Drug Administration has approved Galderma's Nemluvio (nemolizumab) for the treatment of moderate-to-s
byKarolinska InstitutetHuman skin structure. Credit: WikipediaA new study from Karolinska Institutet shows that self-guided cognitive behavioral therapy (CBT) online is as effective as psycholog
byKarolinska InstitutetHuman skin structure. Credit: WikipediaA new study from Karolinska Institutet shows that self-guided cognitive behavioral therapy (CBT) online is as effective as psycholog